Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients.
Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.
Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.
Intended for US audience
Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.
Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital.
Intended for US audience
Location: Switzerland
Employees: 51-200
Total raised: $140.08M
Founded date: 2005
Investors 1
Funding Rounds 4
| Date | Series | Amount | Investors |
| 01.10.2025 | - | $31.32M | GIMV |
| 19.03.2024 | - | $22.61M | - |
| 12.06.2020 | - | $52.51M | - |
| 22.09.2016 | - | $33.63M | - |
Mentions in press and media 14
| Date | Title | Description |
| 17.08.2026 | Two medtechs advance with regulatory approvals | Spineart focuses on designing and developing solutions for spine surgery. One of its foundational technologies and a cornerstone of its cervical portfolio is BAGUERA C, a cervical disc prosthesis designed for disc replacement. Since its in... |
| 01.10.2025 | Spineart secures CHF 25M investment to boost global growth | Spineart’s growth strategy is anchored in a portfolio of cutting-edge technologies designed to make spine surgery safer, more efficient and effective. With a strong focus on clinical outcomes, the company is expanding across Europe and the... |
| 01.10.2025 | Spineart secures CHF 25M investment to boost global growth | Spineart’s growth strategy is anchored in a portfolio of cutting-edge technologies designed to make spine surgery safer, more efficient and effective. With a strong focus on clinical outcomes, the company is expanding across Europe and the... |
| 28.06.2024 | SPINEART APPOINTS LAURENT NODÉ-LANGLOIS AS CHIEF TECHNOLOGY OFFICER TO LEAD ENABLING TECHNOLOGIES BUSINESS UNIT | GENEVA, June 28, 2024 /PRNewswire/ -- Spineart, a fast-growing company specialized in spine surgery innovation, is pleased to announce the appointment of Laurent Nodé-Langlois as Chief Technology Officer. In his new role, Laurent will be ba... |
| 28.05.2024 | Spineart Receives 510(k) Clearance for SCARLET® AC-Ti Anterior Cervical Cage | GENEVA, May 28, 2024 /PRNewswire/ -- Spineart, a fast-growing company specialized in spine surgery, proudly announces the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SCARLET® AC-Ti secured anterior cervical cag... |
| 20.03.2024 | Spineart attracts more than CHF20 million to fuel further growth | Spineart is a Geneva-based medtech company with over €100m (as of 2023) in revenues, is focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, an... |
| 19.03.2024 | Spineart Secures More Than CHF20M in Convertible Financing | Spineart, a Geneva, Switzerland-based spine specialist working with surgeons to accelerate the adoption of technologies, raised more thane CHF20M in convertible financing. Approximately CHF16M of the funding was contributed by existing shar... |
| 11.03.2024 | Artificial Disc Replacement (ADR) Market Predicted to Garner $1.3 Bn by 2030 | CAGR of 12.3% | Vantage Market Research | Vantage Market Research Artificial Disc Replacement Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2030 WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- The Global Artifi... |
| 19.12.2022 | Spineart and Ecential Robotics Annouce a Partnership to Co-develop Spine Surgery Applications and Co-market the Ecential Robotics’ Open Robotic Surgery Platform | Spineart, a leading provider of spine surgery implants and eCential Robotics, a growth MedTech company that designs and produces an open system unifying robotics, surgical navigation, and 2D/3D robotic imaging, announced they entered a long... |
| 12.06.2020 | EGS Beteiligungen invests CHF 50 million in Spineart |
Show more